D.E. Shaw & Co’s Amedisys AMED Stock Holding History

D.E. Shaw & Co’s Portfolio AMED Stock Details AMED Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-6,100	Closed	-$1.05M	–	5312
2022 Q1	$1.05M	Sell	6,100 -50,000	-89%	-$7.47M	﹤0.01%	3881
2021 Q4	$9.08M	Buy	56,100 +26,100	+87%	+$4.19M	0.01%	1751
2021 Q3	$4.47M	Buy	+30,000	New	+$6.24M	﹤0.01%	2211
2019 Q1	–	Sell	-10,200	Closed	-$1.2M	–	3569
2018 Q4	$1.2M	Buy	+10,200	New	+$1.2M	﹤0.01%	2541
2015 Q1	–	Sell	-11,600	Closed	-$340K	–	3605
2014 Q4	$340K	Hold	11,600	–	–	﹤0.01%	3576
2014 Q3	$234K	Buy	+11,600	New	+$224K	﹤0.01%	3813

Other funds holding AMED

Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return

IFP Advisors Tampa, Florida $4.82B AUM 20.19% 1-Year Est. Return

MCI

MRP Capital Investments Alpharetta, Georgia $115M AUM 48.08% 1-Year Est. Return

HNB

Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

D.E. Shaw & Co's AMED Position: Q3 2024 in Review

D.E. Shaw & Co sold out of Amedisys (AMED) in Q3 2024, closing a stake of 3,078 shares — an estimated $283K sold.

D.E. Shaw & Co first reported a position in AMED in Q2 2013 and held it in 45 quarters. The position peaked at $97.4M in Q3 2021. 285 funds tracked by Wall St. Rank hold AMED as of Q3 2024.

D.E. Shaw & Co reported no remaining Amedisys position as of Q3 2024 after selling out during the quarter.
D.E. Shaw & Co sold 3,078 Amedisys shares in Q3 2024, an estimated $283K.
D.E. Shaw & Co first reported a position in Amedisys in Q2 2013 and held it in 45 quarters.
D.E. Shaw & Co's Amedisys position peaked at $97.4M in Q3 2021.
285 funds tracked by Wall St. Rank held Amedisys as of Q3 2024.

Based on D.E. Shaw & Co's 13F filing for Q3 2024, filed 14 Nov 2024.